YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
YRDC 通过调节 KRAS 的翻译介导肝癌细胞对乐伐替尼的耐药性
期刊:Frontiers in Pharmacology
影响因子:4.4
doi:10.3389/fphar.2021.744578
Jun Guo, Peng Zhu, Zhi Ye, Mengke Wang, Haijun Yang, Shiqiong Huang, Yan Shu, Wei Zhang, Honghao Zhou, Qing Li
信号转导
肿瘤
肝癌
肿瘤细胞
FCM
IF
IHC-P
WB
Translational Control
YRDC